FIELD: pharmaceutics.
SUBSTANCE: invention relates to a crystalline form III and a crystalline form IV of N-benzoyl staurosporine (midostaurin), pharmaceutical compositions based thereon.
EFFECT: treatment of leukemia, acute lymphoblastic leukaemia, myelodysplastic syndromes and mastocytosis; preparing pharmaceutical composition by extrusion of melt.
6 cl, 2 tbl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE FORMS OF ALISKIREN HEMIFUMARATE | 2007 |
|
RU2466982C2 |
| METHOD OF STAUROSPORIN PURIFICATION AND METHOD OF OBTAINING N-BENZOYLSTAUROSPORIN | 2005 |
|
RU2467012C2 |
| METHOD OF PRODUCING N-[5-(3,5-DIFTORBENZIL)-1H-INDAZOLE-3-YL]-4-(4-METHYLPIPERAZINE-1-YL)-2-(TETRAHYDROPYRAN-4-YLAMINO)BENZAMIDE | 2013 |
|
RU2602071C2 |
| ORGANIC COMPOUNDS | 2005 |
|
RU2394038C2 |
| MACROCYCLIC POLYMORPHS, COMPOSITIONS CONTAINING SUCH POLYMORPHS, AND METHODS FOR USING AND PREPARING THEM | 2008 |
|
RU2478643C2 |
| CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE, SUITABLE FOR TREATMENT OF ABNORMAL GROWTH OF CELLS IN MAMMALS | 2008 |
|
RU2518898C2 |
| POLYMORPHIC FORMS OF MACROCYCLIC HCV INHIBITOR | 2008 |
|
RU2533830C2 |
| POLYMORPHOUS AND AMORPHOUS FORMS OF {2-FLUORINE-5-[3-((E)-2-PYRIDINE-2-ILVINYL)-1N-INDAZOLE-6-ILAMINE]PHENYL}AMIDE 2, 5-DIMETHYL-2N-PYRAZOLE-3-CARBONIC ACID | 2005 |
|
RU2324692C1 |
| MALEATE SALTS OF QUINAZOLINE DERIVATIVE EFFECTIVE AS ANTIANGIOGENIC AGENT | 2004 |
|
RU2425043C2 |
| BENZOATE SALT OF OTAMIXABAN | 2012 |
|
RU2597423C2 |
